Safety and feasibility of newly developed twist biliary stent in hilar cholangiocarcinoma : A pilot study
- Conditions
- Neoplasms
- Registration Number
- KCT0009258
- Lead Sponsor
- Hallym University Medical Center-Dongtan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 32
? Adult male over 19 years of age, patients diagnosed with hepaticobiliary cancer (Hilar cholangiocarcinoma) by CT, MRI, EUS, or other imaging tests requiring endoscopic retrograde cholangiocarcinoma (ERCP)
? Where participating in a clinical trial, complying with treatment and puncture, and willing to visit a hospital for all follow-up evaluations
In the case of voluntarily signing a written consent form after hearing an explanation of the purpose, method and effectiveness of this clinical trial
? In cases of hemorrhagic disease or coagulation disorder (e.g. DIC) or platelet levels below 60,000/mm3 or INR greater than 1.5
? If anticoagulant therapy cannot be postponed
? When hemodynamically unstable (e.g. shock)
? A woman of childbearing age who is unable to use proper contraception or is pregnant
? In the case of a psychiatric condition or condition in which participation in clinical trials is not possible (e.g. dementia, seizure)
? If the other tester determines that the twist bile stent procedure is impossible
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method